Privia Health Group, Inc. (PRVA)

Market Cap	2.70B
Revenue (ttm)	1.90B
Net Income (ttm)	14.84M
Shares Out	122.73M
EPS (ttm)	0.11
PE Ratio	199.93
Forward PE	85.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	873,118
Open	21.43
Previous Close	21.33
Day's Range	21.43 - 22.06
52-Week Range	16.47 - 26.09
Beta	0.81
Analysts	Strong Buy
Price Target	28.21 (+28.4%)
Earnings Date	Aug 7, 2025

About PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Apr 29, 2021
• Employees: 1,140
• Stock Exchange: NASDAQ
• Ticker Symbol: PRVA
• Website: https://www.priviahealth.com

Financial Performance

In 2024, Privia Health Group's revenue was $1.74 billion, an increase of 4.74% compared to the previous year's $1.66 billion. Earnings were $14.39 million, a decrease of -37.67%.

Analyst Summary

According to 14 analysts, the average rating for PRVA stock is "Strong Buy." The 12-month stock price target is $28.21, which is an increase of 28.40% from the latest price.

Price Target

$28.21

(28.40% upside)

Analyst Consensus: Strong Buy